Supriya Lifescience Ltd: Stock Analysis & Fundamentals

Updated this week

Supriya Lifescience Ltd (Pharma - API & CRAMS) — fundamental analysis, earnings data, and key metrics. PE: 25.5. ROE: 20.8%. This stock is not currently in the Nifty 500 momentum outperformers list.

What's Happening

🏦Virtually debt-free company

🌐FII stake decreased 0.6% this quarter

Key Numbers

Current Price

₹588

Dividend Yield

0.17%

Market Cap

4.7K Cr

Valuation

N/A

Other Top Pharma - API & CRAMS Stocks Beating Nifty 500

Gland Pharma Ltd

Average

+15.9%

Acutaas Chemicals Ltd

SMS Pharmaceuticals Ltd

Average • 12w streak

+37.7%

← Back to Pharma - API & CRAMS Dashboard

Frequently Asked Questions: Supriya Lifescience Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Supriya Lifescience Ltd's latest quarterly results?

Supriya Lifescience Ltd's latest quarterly results (Dec 2025) show

PAT Growth YoY: +6.4%
Revenue Growth YoY: +10.8%
Operating Margin: 35.0%

What is Supriya Lifescience Ltd's current PE ratio?

Supriya Lifescience Ltd's current PE ratio is 25.5x.

Current PE: 25.5x
Market Cap: 4.7K Cr
Dividend Yield: 0.17%

What is Supriya Lifescience Ltd's price-to-book ratio?

Supriya Lifescience Ltd's price-to-book ratio is 4.4x.

Price-to-Book (P/B): 4.4x
Book Value per Share: ₹134
Current Price: ₹588

Is Supriya Lifescience Ltd a fundamentally strong company?

Supriya Lifescience Ltd's fundamental strength based on key financial ratios

Return on Capital (ROCE): 27.0%

Is Supriya Lifescience Ltd debt free?

Supriya Lifescience Ltd has a debt-to-equity ratio of N/A.

Total Debt: ₹5 Cr

What is Supriya Lifescience Ltd's return on equity (ROE) and ROCE?

Supriya Lifescience Ltd's return ratios over recent years

FY2023: ROCE 19.0%
FY2024: ROCE 22.0%
FY2025: ROCE 27.0%

Is Supriya Lifescience Ltd's cash flow positive?

Supriya Lifescience Ltd's operating cash flow is positive (FY2025).

Cash from Operations (CFO): ₹165 Cr
Free Cash Flow (FCF): ₹13 Cr
CFO/PAT Ratio: 88% (strong cash conversion)

What is Supriya Lifescience Ltd's dividend yield?

Supriya Lifescience Ltd's current dividend yield is 0.17%.

Dividend Yield: 0.17%
Current Price: ₹588

Who holds Supriya Lifescience Ltd shares — promoters, FII, DII?

Supriya Lifescience Ltd's shareholding pattern (Dec 2025)

Promoters: 68.3%
FII (Foreign): 5.2%
DII (Domestic): 5.0%
Public: 21.5%

Is promoter holding increasing or decreasing in Supriya Lifescience Ltd?

Supriya Lifescience Ltd's promoter holding has remained stable recently.

Current Promoter Holding: 68.3% (Dec 2025)
Previous Quarter: 68.3% (Sep 2025)
Change: 0.00% (stable)

Is Supriya Lifescience Ltd a new momentum entry or an established outperformer?

Supriya Lifescience Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Supriya Lifescience Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Supriya Lifescience Ltd may be worth studying

Cash flow is positive — CFO ₹165 Cr

What is the investment thesis for Supriya Lifescience Ltd?

Supriya Lifescience Ltd investment thesis summary:

What is the future outlook for Supriya Lifescience Ltd?

Supriya Lifescience Ltd's forward outlook based on current data signals

Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.